Showing results (91-100 of 209) with videos related to
Sort By:
Pageof 21
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 18, 2020
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registryGeorge Ntaios, Menno V Huisman, Hans-Christoph Diener, et al.JAMA|February 11, 2005
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trialGregory W Albers, Hans-Christoph Diener, Lars Frison, et al.Blood|November 12, 2010
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelNeil A Goldenberg, Alex C Spyropoulos, Jonathan L Halperin, et al.European Heart Journal|March 1, 2019
Deep learning for cardiovascular medicine: a practical primerChayakrit Krittanawong, Kipp W Johnson, Robert S Rosenson, et al.Cardiology|June 22, 2021
Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial FibrillationMitchell S V Elkind, Rolf Wachter, Atul Verma, et al.Annals of Internal Medicine|May 21, 2003
Lessons from the Stroke Prevention in Atrial Fibrillation trialsRobert G Hart, Jonathan L Halperin, Lesly A Pearce, et al.American Heart Journal|December 22, 2019
Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF studyJames A Reiffel, Atul Verma, Peter R Kowey, et al.The American Journal of Cardiology|July 16, 2019
Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study)Atul Verma, Rolf Wachter, Peter R Kowey, et al.European Heart Journal|April 17, 2018
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trialMichael D Ezekowitz, Charles V Pollack, Jonathan L Halperin, et al.European Heart Journal|April 25, 2015
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devicesDavid T Martin, Malcolm M Bersohn, Albert L Waldo, et al.Pageof 21